Correlation Between Axsome Therapeutics and Atara Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Axsome Therapeutics and Atara Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Axsome Therapeutics and Atara Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Axsome Therapeutics and Atara Biotherapeutics, you can compare the effects of market volatilities on Axsome Therapeutics and Atara Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Axsome Therapeutics with a short position of Atara Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Axsome Therapeutics and Atara Biotherapeutics.
Diversification Opportunities for Axsome Therapeutics and Atara Biotherapeutics
0.56 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Axsome and Atara is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Axsome Therapeutics and Atara Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Atara Biotherapeutics and Axsome Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Axsome Therapeutics are associated (or correlated) with Atara Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Atara Biotherapeutics has no effect on the direction of Axsome Therapeutics i.e., Axsome Therapeutics and Atara Biotherapeutics go up and down completely randomly.
Pair Corralation between Axsome Therapeutics and Atara Biotherapeutics
Given the investment horizon of 90 days Axsome Therapeutics is expected to generate 0.31 times more return on investment than Atara Biotherapeutics. However, Axsome Therapeutics is 3.2 times less risky than Atara Biotherapeutics. It trades about 0.04 of its potential returns per unit of risk. Atara Biotherapeutics is currently generating about 0.0 per unit of risk. If you would invest 7,115 in Axsome Therapeutics on August 26, 2024 and sell it today you would earn a total of 2,753 from holding Axsome Therapeutics or generate 38.69% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Axsome Therapeutics vs. Atara Biotherapeutics
Performance |
| Timeline |
| Axsome Therapeutics |
| Atara Biotherapeutics |
Axsome Therapeutics and Atara Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Axsome Therapeutics and Atara Biotherapeutics
The main advantage of trading using opposite Axsome Therapeutics and Atara Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Axsome Therapeutics position performs unexpectedly, Atara Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atara Biotherapeutics will offset losses from the drop in Atara Biotherapeutics' long position.| Axsome Therapeutics vs. Incyte | Axsome Therapeutics vs. Sarepta Therapeutics | Axsome Therapeutics vs. ACADIA Pharmaceuticals | Axsome Therapeutics vs. Viking Therapeutics |
| Atara Biotherapeutics vs. Fate Therapeutics | Atara Biotherapeutics vs. Sana Biotechnology | Atara Biotherapeutics vs. Caribou Biosciences | Atara Biotherapeutics vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Stocks Directory Find actively traded stocks across global markets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |